Repository logo
 

Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer.

Published version
Peer-reviewed

Type

Article

Change log

Authors

Zecchini, Vincent 
Madhu, Basetti 
Russell, Roslin 
Pértega-Gomes, Nelma 

Abstract

Tumour cells sustain their high proliferation rate through metabolic reprogramming, whereby cellular metabolism shifts from oxidative phosphorylation to aerobic glycolysis, even under normal oxygen levels. Hypoxia-inducible factor 1A (HIF1A) is a major regulator of this process, but its activation under normoxic conditions, termed pseudohypoxia, is not well documented. Here, using an integrative approach combining the first genome-wide mapping of chromatin binding for an endocytic adaptor, ARRB1, both in vitro and in vivo with gene expression profiling, we demonstrate that nuclear ARRB1 contributes to this metabolic shift in prostate cancer cells via regulation of HIF1A transcriptional activity under normoxic conditions through regulation of succinate dehydrogenase A (SDHA) and fumarate hydratase (FH) expression. ARRB1-induced pseudohypoxia may facilitate adaptation of cancer cells to growth in the harsh conditions that are frequently encountered within solid tumours. Our study is the first example of an endocytic adaptor protein regulating metabolic pathways. It implicates ARRB1 as a potential tumour promoter in prostate cancer and highlights the importance of metabolic alterations in prostate cancer.

Description

Keywords

Adaptor, hypoxia, metabolism, prostate, transcription, Arrestins, Chromatin Immunoprecipitation, Fluorescent Antibody Technique, Fumarate Hydratase, Gas Chromatography-Mass Spectrometry, Gene Expression Profiling, Humans, Hypoxia-Inducible Factor 1, alpha Subunit, Immunoblotting, Immunohistochemistry, Magnetic Resonance Spectroscopy, Male, Metabolic Networks and Pathways, Metabolomics, Models, Biological, Prostatic Neoplasms, RNA Interference, Succinate Dehydrogenase, Tissue Array Analysis, beta-Arrestin 1, beta-Arrestins

Journal Title

EMBO J

Conference Name

Journal ISSN

0261-4189
1460-2075

Volume Title

33

Publisher

Springer Science and Business Media LLC
Sponsorship
Medical Research Council (G0900871)
Medical Research Council (MC_UU_12022/6)
Cancer Research UK (17242)
Cancer Research UK (11562)